Predicting death from HIV/AIDS: A case-control study from Florida public HIV/AIDS clinics

Journal of Acquired Immune Deficiency Syndromes

Volumn 30, Issue 3, 2002, Pages 351-358

  Lieb, Spencer ^a   Brooks, Robert G ^a   Hopkins, Richard S ^a   Thompson, Dan ^a   Crockett, Landis K ^a   Liberti, Thomas ^a   Jani, Asim A ^a   Nadler, Jeffrey P ^a   Virkud, Vikas M ^a   West, Karen C ^a   McLaughlin, Gayle ^a  

^a FLORIDA DEPARTMENT OF HEALTH   (United States)

Author keywords

AIDS; HIV; Mortality

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; HEALTH CENTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAID; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK FACTOR; SOCIAL BEHAVIOR; UNITED STATES; URBAN AREA;

EID: 0036640561     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200207010-00012     Document Type: Article

References (41)

1. HIV in the United States at the turn of the century: An epidemic in transition
2. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
3. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration
4. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
5. Nonadherence to triple combination therapy is predictive of AIDS progression and death in HIV-positive men and women
6. Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART
7. Barriers to adherence to highly active antiretroviral therapy as expressed by people living with HIV/AIDS
8. Interactions among drugs for HIV and opportunistic infections
9. Transmission of drug-resistant strains of HIV-1: Unfortunate, but inevitable
10. Delayed medical care after diagnosis in a US national probability sample of persons infected with human immunodeficiency virus
11. Survival patterns among HIV+ individuals based on health care utilization
12. The prospective effect of access to medical care on health-related quality-of-life outcomes in patients with symptomatic HIV disease
13. Variations in the care of HIV-infected adults in the United States
14. Slowing decline in AIDS deaths prompts concerns
15. HIV prevalence and associated risks in young men who have sex with men
16. HIV prevention research: Progress and challenges in the new millennium
17. The gay '90s: A review of research in the 1990s on sexual behavior and HIV risk among men who have sex with men
18. Coding changes and apparent HIV/AIDS mortality trends in Florida, 1999
19. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
20. Host determinants in HIV infection and disease, part 1: Cellular and humoral immune responses
21. Host determinants in HIV infection and disease, part 2: Genetic factors and implications for antiretroviral therapeutics
22. Changing spectrum of mortality due to human immunodeficiency virus: Analysis of 260 deaths during 1995-1999
23. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: The Swiss HIV cohort study
24. Hepatitis C virus is related to progressive liver disease in human immunodeficiency virus-positive hemophiliacs and should be treated as an opportunistic infection
25. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
26. Influence of hepatitis C virus infection on the mortality of antiretroviral-treated patients with HIV disease
27. Hepatitis C in the HIV (Human Immunodeficiency Virus) Atlanta V.A. (Veterans Affairs Medical Center) cohort study (HAVACS): The effect of coinfection on survival
28. Mortality for liver disease in patients with HIV infection: A cohort study
29. Cofactors for HIV disease progression in a cohort of homosexual and bisexual men
30. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis
31. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease
32. Impact of protease inhibitors and other antiretroviral treatments on acquired immunodeficiency syndrome in San Francisco, California, 1987-1996
33. Differential access in the receipt of antiretroviral drugs for the treatment of AIDS and its implications for survival
34. Effect of influenza vaccination on disease progression among HIV-infected persons
35. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
36. The risk of disease progression is determined during first year of human immunodeficiency virus type 1 infection
37. 6 cells/L
38. A comparison study of multiple measures of adherence to HIV protease inhibitors
39. An innovative approach to improve medication adherence in an urban public health clinic
40. A team approach to address antiretroviral therapy adherence barriers in a managed care organization
41. Treatment adherence improves outcomes and manages costs